Has the association between saturated fatty acids, serum cholesterol and coronary heart disease been over emphasized?

[1]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[2]  S. Grundy.  Metabolic Syndrome Pandemic , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[3]  G. Major,et al.  Recent developments in calcium‐related obesity research , 2008, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[4]  D. I. Givens,et al.  The Survival Advantage of Milk and Dairy Consumption: an Overview of Evidence from Cohort Studies of Vascular Diseases, Diabetes and Cancer , 2008, Journal of the American College of Nutrition.

[5]  Peter Libby,et al.  Inflammation in Atherosclerosis : From Vascular Biology to Biomarker Discovery and Risk Prediction , 2007 .

[6]  J. Borén,et al.  Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update , 2007 .

[7]  R. Krauss,et al.  Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins. , 2007, The American journal of clinical nutrition.

[8]  R. Korpela,et al.  Milk peptides and blood pressure. , 2007, The Journal of nutrition.

[9]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[10]  M Alan Brookhart,et al.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.

[11]  F. Sacks.  The apolipoprotein story. , 2006, Atherosclerosis. Supplements.

[12]  D. Steinberg,et al.  Thematic review series : The Pathogenesis of Atherosclerosis An interpretive history of the cholesterol controversy , part V : The discovery of the statins and the end of the controversy 1 , 2006 .

[13]  J. Danesh,et al.  Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature‐based meta‐analysis of prospective studies , 2006, Journal of internal medicine.

[14]  D. Arveiler,et al.  Independent contribution of dairy products and calcium intake to blood pressure variations at a population level , 2006, Journal of hypertension.

[15]  J. Manson,et al.  Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. , 2006, JAMA.

[16]  P. Libby,et al.  Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells , 2006, Circulation.

[17]  Peter Libby,et al.  Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.

[18]  M. Rizzo,et al.  Low-density lipoprotein size and cardiovascular risk assessment. , 2006, QJM : monthly journal of the Association of Physicians.

[19]  J. Liao.  Clinical implications for statin pleiotropy , 2005, Current opinion in lipidology.

[20]  Nader Rifai,et al.  Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men , 2005, Circulation.

[21]  R. Krauss.  Dietary and genetic probes of atherogenic dyslipidemia. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[23]  H. Boshuizen,et al.  Effect Size Estimates of Lifestyle and Dietary Changes on All-Cause Mortality in Coronary Artery Disease Patients: A Systematic Review , 2005, Circulation.

[24]  G. Berglund,et al.  Dietary fat intake and early mortality patterns – data from The Malmö Diet and Cancer Study , 2005, Journal of internal medicine.

[25]  M. Davidson.  Clinical significance of statin pleiotropic effects: hypotheses versus evidence. , 2005, Circulation.

[26]  W. März,et al.  Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans , 2005, Circulation.

[27]  M. Briel,et al.  Effect of different antilipidemic agents and diets on mortality: a systematic review. , 2005, Archives of internal medicine.

[28]  J. Manson,et al.  Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. , 2005, American journal of epidemiology.

[29]  J. Fleg,et al.  The combination of high fruit and vegetable and low saturated fat intakes is more protective against mortality in aging men than is either alone: the Baltimore Longitudinal Study of Aging. , 2005, The Journal of nutrition.

[30]  M. Pfeffer,et al.  C-reactive protein levels and outcomes after statin therapy. , 2005, The New England journal of medicine.

[31]  C. Cannon,et al.  Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology , 2004, Current opinion in lipidology.

[32]  I. Goldberg,et al.  Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  D. Mozaffarian,et al.  Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. , 2004, The American journal of clinical nutrition.

[34]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[35]  D. Capuzzi,et al.  High-density lipoprotein subfractions and risk of coronary artery disease , 2004, Current atherosclerosis reports.

[36]  K. Overvad,et al.  Dietary fat and risk of coronary heart disease: possible effect modification by gender and age. , 2004, American journal of epidemiology.

[37]  A. Hamsten,et al.  Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. , 2004, The Journal of nutrition.

[38]  J. Davignon.  Beneficial Cardiovascular Pleiotropic Effects of Statins , 2004, Circulation.

[39]  Richard M. Moe,et al.  Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. , 2004, Journal of the American College of Cardiology.

[40]  P. Libby,et al.  Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents? , 2004, Circulation.

[41]  P. Elwood,et al.  Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies , 2004, European Journal of Clinical Nutrition.

[42]  J. Witztum,et al.  Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a) , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[43]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[44]  K. Kawecka-Jaszcz,et al.  Lipid-lowering drugs and homocysteine. A comparison between statins and other lipid-lowering drugs. , 2004, Atherosclerosis.

[45]  S. Ylä-Herttuala,et al.  Gene Expression in Macrophage-Rich Inflammatory Cell Infiltrates in Human Atherosclerotic Lesions as Studied by Laser Microdissection and DNA Array: Overexpression of HMG-CoA Reductase, Colony Stimulating Factor Receptors, CD11A/CD18 Integrins, and Interleukin Receptors , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[46]  E. Kabagambe,et al.  Individual saturated fatty acids and nonfatal acute myocardial infarction in Costa Rica , 2003, European Journal of Clinical Nutrition.

[47]  R. Karas,et al.  Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease , 2003, Annals of Internal Medicine.

[48]  M. Hori,et al.  Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy , 2003, Circulation.

[49]  F. Sacks,et al.  LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[50]  R. Mensink,et al.  Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. , 2003, The American journal of clinical nutrition.

[51]  P. Ridker.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[52]  F. Sacks,et al.  Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. , 2002, The American journal of medicine.

[53]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[54]  D. Pella,et al.  Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial , 2002, The Lancet.

[55]  Brian J. Bennett,et al.  Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[56]  J. Witztum,et al.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Kathleen M. Weil,et al.  Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction , 2002, Circulation.

[58]  D. Boniface,et al.  Dietary fats and 16-year coronary heart disease mortality in a cohort of men and women in Great Britain , 2002, European Journal of Clinical Nutrition.

[59]  Ted J. Kaptchuk,et al.  The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance? , 2002, Annals of Internal Medicine.

[60]  S. Tsimikas,et al.  Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis. , 2002, Journal of the American Society of Nephrology : JASN.

[61]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study☆ , 2002 .

[62]  A. Keech,et al.  Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial: To What Extent Is the Reduction in Coronary Events With Pravastatin Explained by On-Study Lipid Levels? , 2002, Circulation.

[63]  E. Schaefer,et al.  Lipoproteins, nutrition, and heart disease. , 2002, The American journal of clinical nutrition.

[64]  J. Manson,et al.  A prospective study of dietary fiber intake and risk of cardiovascular disease among women. , 2002, Journal of the American College of Cardiology.

[65]  I. Holme,et al.  High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study , 2001, The Lancet.

[66]  U. Laufs,et al.  Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. , 2001, The American journal of cardiology.

[67]  J. Liao,et al.  Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[68]  M. Salmona,et al.  In Vivo Anti-Inflammatory Effect of Statins Is Mediated by Nonsterol Mevalonate Products , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[69]  R. Gerszten,et al.  HMG-CoA Reductase Inhibitor Modulates Monocyte-Endothelial Cell Interaction Under Physiological Flow Conditions In Vitro: Involvement of Rho GTPase-Dependent Mechanism , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[70]  Joerg Kallen,et al.  Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site , 2001, Nature Medicine.

[71]  Michael F. Oliver,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.

[72]  B. Psaty,et al.  Moderate dietary fat consumption as a risk factor for ischemic heart disease in a population with a low fat intake: a case-control study in Korean men. , 2001, The American journal of clinical nutrition.

[73]  D. Steinberg,et al.  The oxidative modification hypothesis of atherosclerosis: does it hold for humans? , 2001, Trends in cardiovascular medicine.

[74]  Shah Ebrahim,et al.  Dietary fat intake and prevention of cardiovascular disease: systematic review , 2001, BMJ : British Medical Journal.

[75]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[76]  P W Macfarlane,et al.  Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study , 2001, Circulation.

[77]  Y. Chao,et al.  Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[78]  R. Krauss.  Dietary and genetic effects on low-density lipoprotein heterogeneity. , 2001, Annual review of nutrition.

[79]  P. Libby,et al.  Cholesterol and atherosclerosis. , 2000, Biochimica et biophysica acta.

[80]  A. Keech,et al.  Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project , 2000, Circulation.

[81]  M. Pfeffer,et al.  VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial , 2000, Circulation.

[82]  J. Danesh,et al.  Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies , 2000, Circulation.

[83]  J. Manson,et al.  Primary prevention of coronary heart disease in women through diet and lifestyle. , 2000, The New England journal of medicine.

[84]  M. Linton,et al.  Current perspectives on statins. , 2000, Circulation.

[85]  F. Bernini,et al.  Non-lipid-related effects of statins , 2000, Annals of medicine.

[86]  T. McLaughlin,et al.  High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. , 2000, American Journal of Cardiology.

[87]  Archbold Ra,et al.  Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies. , 1999, Current opinion in lipidology.

[88]  J. Manson,et al.  Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. , 1999, The American journal of clinical nutrition.

[89]  M. Lefevre,et al.  HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. , 1999, The American journal of clinical nutrition.

[90]  M. Pahor,et al.  Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. , 1999, Hypertension.

[91]  W. Willett,et al.  Trans fatty acids and coronary heart disease. , 1999, The New England journal of medicine.

[92]  R. Krauss,et al.  A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. , 1999, The American journal of clinical nutrition.

[93]  D A Katerndahl,et al.  Variability in meta-analytic results concerning the value of cholesterol reduction in coronary heart disease: a meta-meta-analysis. , 1999, American journal of epidemiology.

[94]  B. Griffin,et al.  Lipoprotein atherogenicity: an overview of current mechanisms , 1999, Proceedings of the Nutrition Society.

[95]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[96]  R. Krauss,et al.  Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. , 1998, The American journal of clinical nutrition.

[97]  G. Thorgeirsson,et al.  Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) , 1998, Circulation.

[98]  P. Macfarlane,et al.  Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). , 1998, Circulation.

[99]  B. Davis,et al.  Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. , 1998, Circulation.

[100]  P. Kris-Etherton,et al.  Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[101]  P. Libby,et al.  Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. , 1998, Journal of the American College of Cardiology.

[102]  G A Colditz,et al.  Dietary fat intake and the risk of coronary heart disease in women. , 1997, The New England journal of medicine.

[103]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[104]  J. Wittes,et al.  Plasma lipoprotein (a) levels in men and women consuming diets enriched in saturated, cis-, or trans-monounsaturated fatty acids. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[105]  W C Willett,et al.  Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. , 1997, American journal of epidemiology.

[106]  M. Jauhiainen,et al.  Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. , 1997, The American journal of clinical nutrition.

[107]  W. Castelli,et al.  Margarine Intake and Subsequent Coronary Heart Disease in Men , 1997, Epidemiology.

[108]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[109]  R. Krauss,et al.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. , 1996, JAMA.

[110]  E. Rimm,et al.  Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States , 1996, BMJ.

[111]  E. Rimm,et al.  Alcohol consumption and coronary heart disease: good habits may be more important than just good wine. , 1996, American journal of epidemiology.

[112]  R. Mensink,et al.  Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. , 1996, The American journal of clinical nutrition.

[113]  L. Joseph,et al.  Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. , 1996, Journal of clinical epidemiology.

[114]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .

[115]  J. Ordovás,et al.  Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[116]  D Kromhout,et al.  Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. , 1995, JAMA.

[117]  B. Vessby,et al.  Effect of fats high in individual saturated fatty acids on plasma lipoprotein[a] levels in young healthy men. , 1995, Journal of lipid research.

[118]  T. Wilt,et al.  Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. , 1995, The American journal of cardiology.

[119]  R. Krauss,et al.  Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns. , 1995, The American journal of clinical nutrition.

[120]  J. I. Pedersen,et al.  Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. , 1995, Journal of lipid research.

[121]  K. Williams,et al.  The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[122]  B. Vessby,et al.  Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. , 1994, The American journal of clinical nutrition.

[123]  B. Rosner,et al.  Effect on coronary atherosclerosis of decrease in plasma cholesterol concentrations in normocholesterolaemic patients , 1994, The Lancet.

[124]  P. Touboul,et al.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease , 1994, The Lancet.

[125]  M. Katan,et al.  Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[126]  A. Trichopoulou,et al.  Diet and coronary heart disease: a case-control study in Athens, Greece. , 1993, Epidemiology.

[127]  G E Dallal,et al.  Dietary fat and serum lipids: an evaluation of the experimental data. , 1993, The American journal of clinical nutrition.

[128]  G. Ginsburg,et al.  High-density lipoprotein subfractions. , 1993, The American journal of medicine.

[129]  F. Song,et al.  Cholesterol lowering and mortality: the importance of considering initial level of risk. , 1993, BMJ.

[130]  P. Elwood,et al.  Diet and incident ischaemic heart disease: the Caerphilly Study , 1993, British Journal of Nutrition.

[131]  J. Derr,et al.  The role of fatty acid saturation on plasma lipids, lipoproteins, and apolipoproteins: II. The plasma total and low-density lipoprotein cholesterol response of individual fatty acids. , 1993, Metabolism: Clinical and Experimental.

[132]  J. Medalie,et al.  Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. , 1993, Cardiology.

[133]  P. Wilson,et al.  LDL particle size distribution. Results from the Framingham Offspring Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[134]  S. Grundy,et al.  Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. , 1992, The American journal of clinical nutrition.

[135]  R. Mensink,et al.  Effect of dietary cis and trans fatty acids on serum lipoprotein[a] levels in humans. , 1992, Journal of lipid research.

[136]  R. Mensink,et al.  Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[137]  Richard H. Myers,et al.  Familial Lipoprotein Disorders in Patients With Premature Coronary Artery Disease , 1992, Circulation.

[138]  R. Singh,et al.  Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. , 1992, BMJ.

[139]  K. Anderson,et al.  Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. , 1992, Journal of the American College of Cardiology.

[140]  P. Taylor,et al.  Plasma lipid and lipoprotein concentrations of men consuming a low-fat, high-fiber diet. , 1992, The American journal of clinical nutrition.

[141]  M. Woodward,et al.  The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. I. The macronutrients. , 1992, European journal of clinical nutrition.

[142]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[143]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[144]  M. Marmot,et al.  Plasma cholesterol concentration and mortality. The Whitehall Study. , 1992, JAMA.

[145]  W. Willett,et al.  A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. , 1991, The New England journal of medicine.

[146]  R. D'Agostino,et al.  Dietary lipid predictors of coronary heart disease in men. The Framingham Study. , 1991, Archives of internal medicine.

[147]  D. Salem,et al.  Prevalence of risk factors in men with premature coronary artery disease. , 1991, The American journal of cardiology.

[148]  K. Mccully,et al.  Homocysteine content of lipoproteins in hypercholesterolemia. , 1991, Atherosclerosis.

[149]  J. Fruchart,et al.  Lowering of HDL2-cholesterol and lipoprotein A-I particle levels by increasing the ratio of polyunsaturated to saturated fatty acids. , 1991, The American journal of clinical nutrition.

[150]  P. Allhoff,et al.  The Multifactor Primary Prevention Trial in Göteborg , 1991 .

[151]  A. Sniderman,et al.  Is it time to measure apolipoprotein B? , 1990, Arteriosclerosis.

[152]  J Pekkanen,et al.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. , 1990, The New England journal of medicine.

[153]  D. Gordon,et al.  High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.

[154]  A. Menotti,et al.  Diet and 20-y mortality in two rural population groups of middle-aged men in Italy. , 1989, The American journal of clinical nutrition.

[155]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[156]  P. Clifton,et al.  Effect of dietary cholesterol in normolipidemic subjects is not modified by nature and amount of dietary fat. , 1989, The American journal of clinical nutrition.

[157]  L. Gatewood,et al.  Test of Effect of Lipid Lowering by Diet on Cardiovascular Risk: The Minnesota Coronary Survey , 1989, Arteriosclerosis.

[158]  M. Katan,et al.  Congruence of individual responsiveness to dietary cholesterol and to saturated fat in humans. , 1988, Journal of lipid research.

[159]  S. Grundy,et al.  Plasma cholesterol responsiveness to saturated fatty acids. , 1988, The American journal of clinical nutrition.

[160]  T. Gordon,et al.  The diet-heart idea. Outline of a history. , 1988, American journal of epidemiology.

[161]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[162]  E. Barrett-Connor,et al.  DIETARY FIBER AND REDUCED ISCREMIC HEART DISEASE MORTALITY RATES IT MEN AND WOMEN: A 12-YEAR PROSPECTIVE STUDY , 1987 .

[163]  D. Reed,et al.  Predictors of atherosclerosis in the Honolulu Heart Program. I. Biologic, dietary, and lifestyle characteristics. , 1987, American journal of epidemiology.

[164]  D. Levy,et al.  Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.

[165]  N. Miller.  Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. , 1987, American heart journal.

[166]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[167]  G. Berglund,et al.  The Multifactor Primary Prevention Trial in Göteborg, Sweden. Comparison with a previously untreated population sample. , 1986, Drugs.

[168]  H. Sewell,et al.  Cytochrome P-450 immunolocalization in human liver. , 1986, Lancet.

[169]  L. Carlson,et al.  Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. , 2009, Acta medica Scandinavica.

[170]  R. Lew,et al.  Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. , 1985, The New England journal of medicine.

[171]  J. Stanton,et al.  Blood pressure and nutrient intake in the United States , 1984 .

[172]  Daniel L. McGee,et al.  Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics. , 1984, American journal of epidemiology.

[173]  D. Kromhout,et al.  Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. The Zutphen Study. , 1984, American journal of epidemiology.

[174]  D. McGee,et al.  Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to nutrient intake. , 1984, American journal of epidemiology.

[175]  D. Jacobs,et al.  Variability in Individual Serum Cholesterol Response to Change in Diet , 1983, Arteriosclerosis.

[176]  G. Schonfeld,et al.  Effects of dietary cholesterol and fatty acids on plasma lipoproteins. , 1982, The Journal of clinical investigation.

[177]  I. Holme,et al.  EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE Report from the Oslo Study Group of a Randomised Trial in Healthy Men , 1981, The Lancet.

[178]  J. Strong,et al.  Dietary-atherosclerosis study on deceased persons. , 1981, Journal of the American Dietetic Association.

[179]  P. D. Wood.  A Possible Selection Effect in Medical Science , 1981 .

[180]  W. Kannel,et al.  Diet and Its Relation to Coronary Heart Disease and Death in Three Populations , 1981, Circulation.

[181]  W. Raynor,et al.  Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. , 1981, The New England journal of medicine.

[182]  P. Sorlie,et al.  Relationship of dietary intake to subsequent coronary heart disease incidence: The Puerto Rico Heart Health Program. , 1980, The American journal of clinical nutrition.

[183]  M. Karvonen,et al.  Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study. , 1979, International journal of epidemiology.

[184]  W. Kannel,et al.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. , 1979, Annals of internal medicine.

[185]  K. Yano,et al.  Dietary intake and the risk of coronary heart disease in Japanese men living in Hawaii. , 1978, The American journal of clinical nutrition.

[186]  J. Stamler,et al.  George Lyman Duff Memorial Lecture. Lifestyles, major risk factors, proof and public policy. , 1978, Circulation.

[187]  C. Mcgilchrist,et al.  Low fat, low cholesterol diet in secondary prevention of coronary heart disease. , 1978, Advances in experimental medicine and biology.

[188]  J. Marr,et al.  Diet and heart: a postscript. , 1977, British medical journal.

[189]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[190]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[191]  Strong Jp,et al.  Dietary-atherosclerosis study on deceased persons. Relation of selected dietary components to raised coronary lesions. , 1976 .

[192]  H. Wisniewski,et al.  IMMUNOSUPPRESSION BY LINOLEIC ACID , 1975, The Lancet.

[193]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[194]  J. Medalie,et al.  Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. , 1973, Journal of chronic diseases.

[195]  R. Masironi.  Dietary factors and coronary heart disease. , 1970, Bulletin of the World Health Organization.

[196]  D. Bassett,et al.  Coronary heart disease in Hawaii: dietary intake, depot fat, "stress", smoking, and energy balance in Hawaiian and Japanese men. , 1969, The American journal of clinical nutrition.

[197]  U. Tomiyasu,et al.  A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of Atherosclerosis , 1969 .

[198]  P. Leren.  The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. , 1968, Bulletin of the New York Academy of Medicine.

[199]  R. Mulcahy,et al.  Diet and Coronary Heart Disease: Dietary Analysis on 100 Male Patients , 1968 .

[200]  J. N. Morris.  Controlled trial of soyabean oil in myocardial infarction. , 1968 .

[201]  P. Allhoff,et al.  Controlled trial of soya-bean oil in myocardial infarction. , 1968, Lancet.

[202]  D. Hegsted,et al.  Quantitative effects of dietary fat on serum cholesterol in man. , 1965, The American journal of clinical nutrition.

[203]  L. Michaels,et al.  LOW-FAT DIET IN MYOCARDIAL INFARCTION , 1965 .

[204]  A. Keys,et al.  Serum cholesterol response to changes in the diet: II. The effect of cholesterol in the diet. , 1965, Metabolism: clinical and experimental.

[205]  A. Keys,et al.  Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. , 1965, Metabolism: clinical and experimental.

[206]  W. B. Thomson,et al.  Corn Oil in Treatment of Ischaemic Heart Disease , 1965, British medical journal.

[207]  W. H. Phelan,et al.  A Longitudinal Study of Coronary Heart Disease , 1963, Circulation.

[208]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[209]  R. Painter,et al.  A short-term community study of the epidemiology of coronary heart disease. A preliminary report on the North Dakota study. , 1959, American journal of public health and the nation's health.

[210]  I. Browne,et al.  The management of the acute withdrawal phase in alcoholism. , 1959, Lancet.

[211]  A. Keys,et al.  Prediction of serum-cholesterol responses of man to changes in fats in the diet. , 1957, Lancet.

[212]  J. Yudkin.  DIET AND CORONARY THROMBOSIS , 1957 .

[213]  J. Yudkin.  Diet and coronary thrombosis hypothesis and fact. , 1957, Lancet.

[214]  J. Yerushalmy,et al.  Fat in the diet and mortality from heart disease; a methodologic note. , 1957, New York state journal of medicine.

[215]  W. Insull,et al.  The influence of dietary fats on serum-lipid levels in man. , 1957, Lancet.

[216]  D. Blankenhorn,et al.  Effect on Human Serum Lipids of Substituting Plant for Animal Fat in Diet.∗ , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[217]  H. Eder,et al.  Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions. , 1951, The American journal of medicine.

[218]  I. Chaikoff,et al.  Intestinal lymph as pathway for transport of absorbed fatty acids of different chain lengths. , 1951, The American journal of physiology.

[219]  T. Dawber,et al.  Epidemiological approaches to heart disease: the Framingham Study. , 1951, American journal of public health and the nation's health.